Haemonetics Long-Term Investments 2010-2024 | HAE

Haemonetics long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
Haemonetics Annual Long-Term Investments
(Millions of US $)
2024 $
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Haemonetics Quarterly Long-Term Investments
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.763B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $204.059B 26.03
Stryker (SYK) United States $139.868B 31.52
Boston Scientific (BSX) United States $124.863B 35.90
Medtronic (MDT) Ireland $114.537B 17.04
EssilorLuxottica (ESLOY) France $110.799B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.365B 0.00
Haleon (HLN) United Kingdom $44.180B 28.71
GE HealthCare Technologies (GEHC) United States $39.743B 20.61
ResMed (RMD) United States $35.761B 29.39
Terumo (TRUMY) Japan $28.532B 40.29
Koninklijke Philips (PHG) Netherlands $25.454B 19.48
Zimmer Biomet Holdings (ZBH) United States $21.582B 13.74
Baxter (BAX) United States $18.264B 12.39
Insulet (PODD) United States $16.648B 70.04
Smith & Nephew SNATS (SNN) United Kingdom $11.052B 0.00
Bio-Rad Laboratories (BIO) United States $10.282B 35.10
BellRing Brands (BRBR) United States $8.726B 36.90
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $8.016B 19.24
ICU Medical (ICUI) United States $4.201B 40.09
TG Therapeutics (TGTX) United States $3.771B 0.00
Envista Holdings (NVST) United States $3.662B 27.28
Prestige Consumer Healthcare (PBH) United States $3.657B 18.22
Perrigo (PRGO) Ireland $3.466B 10.95
Neogen (NEOG) United States $3.127B 36.08
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.988B 18.00
QuidelOrtho (QDEL) United States $2.628B 16.56
Agios Pharmaceuticals (AGIO) United States $2.557B 0.00
Green Thumb Industries (GTBIF) United States $2.260B 38.14
LeMaitre Vascular (LMAT) United States $2.165B 52.65
Curaleaf Holdings (CURLF) Canada $2.023B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.960B 0.00
Warby Parker (WRBY) United States $1.769B 0.00
AtriCure (ATRC) United States $1.641B 0.00
InMode (INMD) Israel $1.460B 8.78
AdaptHealth (AHCO) United States $1.365B 9.85
Verano Holdings (VRNOF) United States $1.231B 0.00
BioLife Solutions (BLFS) United States $1.179B 0.00
Evolus (EOLS) United States $1.036B 0.00
Owens & Minor (OMI) United States $0.925B 7.23
National Vision Holdings (EYE) United States $0.915B 29.08
Phibro Animal Health (PAHC) United States $0.906B 18.80
CeriBell (CBLL) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.844B 0.00
Cresco Labs (CRLBF) United States $0.747B 0.00
VAREX IMAGING (VREX) United States $0.542B 16.36
Surmodics (SRDX) United States $0.536B 113.85
Quanterix (QTRX) United States $0.532B 0.00
Canopy Growth (CGC) Canada $0.515B 0.00
Valneva SE (VALN) France $0.475B 0.00
ZimVie (ZIMV) United States $0.398B 33.56
Viemed Healthcare (VMD) United States $0.331B 35.54
Aurora Cannabis (ACB) Canada $0.328B 0.00
OraSure Technologies (OSUR) United States $0.315B 8.12
TerrAscend (TSNDF) Canada $0.309B 0.00
Jin Medical (ZJYL) China $0.308B 0.00
Sanara MedTech (SMTI) United States $0.293B 0.00
Cerus (CERS) United States $0.290B 0.00
Biote (BTMD) United States $0.280B 12.93
Ayr Wellness (AYRWF) United States $0.279B 0.00
Zynex (ZYXI) United States $0.255B 53.33
Omeros (OMER) United States $0.246B 0.00
High Tide (HITI) Canada $0.234B 97.00
MacroGenics (MGNX) United States $0.232B 0.00
Utah Medical Products (UTMD) United States $0.225B 15.14
Organigram Holdings (OGI) Canada $0.195B 0.00
Brainsway (BWAY) Israel $0.172B 206.40
FitLife Brands (FTLF) United States $0.145B 19.54
Rockwell Medical (RMTI) United States $0.121B 0.00
TriSalus Life Sciences (TLSI) United States $0.117B 0.00
Quipt Home Medical (QIPT) United States $0.113B 0.00
Veru (VERU) United States $0.107B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 23.90
Fonar (FONR) United States $0.092B 9.51
Jushi Holdings (JUSHF) United States $0.092B 0.00
Cellectar Biosciences (CLRB) United States $0.082B 0.00
Zevia PBC (ZVIA) United States $0.079B 0.00
InterCure (INCR) Israel $0.079B 0.00
Modular Medical (MODD) United States $0.073B 0.00
Safety Shot (SHOT) United States $0.065B 0.00
Sanuwave Health (SNWVD) United States $0.064B 1.63
MariMed (MRMD) United States $0.062B 0.00
Cytosorbents (CTSO) United States $0.047B 0.00
Allurion Technologies (ALUR) United States $0.045B 0.00
Exagen (XGN) United States $0.043B 0.00
Apyx Medical (APYX) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Nephros (NEPH) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
GlucoTrack (GCTK) United States $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 17.87
SNDL (SNDL) Canada $0.000B 0.00